Additionally, immunohistochemistry (IHC) confirmed a dramatic loss of SMARCA4 and POU2F3 protein expression in the AU-24118-treated SCLC-P samples, as well as decreased DCLK1 expression - a tuft cell marker (Fig. 3D, Fig. S5C). The gene discussed is SMARCA4; the disease is small cell lung carcinoma.